Morgan Stanley analyst John Glass maintains Starbucks (NASDAQ:SBUX) with a Equal-Weight and raises the price target from $88 to $96.
HC Wainwright & Co. Initiates Coverage On Belite Bio with Buy Rating, Announces Price Target of $58
HC Wainwright & Co. analyst Yi Chen initiates coverage on Belite Bio (NASDAQ:BLTE) with a Buy rating and announces Price Target of $58.